Health score, competitive moat, risk signals, and key metrics at a glance.
Competitive analysis based on 54 quarters of fundamental data
Operating margins are positive at ~6.0% on average, but show some variability — pricing power may be sensitive to market conditions.
ROE is low or negative, suggesting limited competitive advantage or capital allocation challenges.
Data-driven red flags and warnings across 54 quarters
Operating margins dropped 20.2% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.
Free cash flow has been negative in 8 of the last 8 quarters — earnings are not translating to cash.
D/E ratio of 2.6 is elevated and rising. Monitor for further debt accumulation.
Revenue is stable or growing over recent quarters — demand appears durable.
The last 8 consecutive quarters had negative FCF — the company is burning cash and may need external funding.
Share count is stable — no significant dilution or buyback activity.
as of September 2025
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Only 0 of the last 8 quarters had positive FCF — the business may require external capital to sustain operations.
TTM revenue has grown consistently (7 of 7 quarters up), with ~6.4% growth over the period. Strong demand durability.
